EPAS1 and neuroblastoma: This remarkable cancer-type specificity of HIF2α oncogenic activity reinforces the view that its role is highly context-dependent, and that in neuroblastoma, lacking VHL mutations, HIF2α may serve a different, potentially tumor-suppressive function.